Advances in Biology and Therapy of Multiple Myeloma Volume 2: Translational and Clinical Research /

Despite the advances in conventional, and novel agent and high dose chemotherapy, multiple myeloma remains incurable. In order to overcome resistance to current therapies and improve patient outcome, novel biologically-based treatment approaches are being developed. Current translational research in...

Full description

Bibliographic Details
Published in:Springer eBooks
Corporate Author: SpringerLink (Online service)
Other Authors: Munshi, Nikhil C. (Editor), Anderson, Kenneth C. (Editor)
Format: eBook
Language:English
Published: New York, NY : Springer New York : Imprint: Springer, 2013.
Subjects:
Online Access:http://dx.doi.org/10.1007/978-1-4614-5260-7
Перейти в каталог НБ ТГУ
LEADER 03144nam a22004695i 4500
001 vtls000483688
003 RU-ToGU
005 20210922065815.0
007 cr nn 008mamaa
008 140715s2013 xxu| s |||| 0|eng d
020 |a 9781461452607  |9 978-1-4614-5260-7 
024 7 |a 10.1007/978-1-4614-5260-7  |2 doi 
035 |a to000483688 
039 9 |y 201407151936  |z Александр Эльверович Гилязов 
040 |a Springer  |c Springer  |d RU-ToGU 
050 4 |a RC261-271 
072 7 |a MJCL  |2 bicssc 
072 7 |a MED062000  |2 bisacsh 
082 0 4 |a 614.5999  |2 23 
100 1 |a Munshi, Nikhil C.  |e editor.  |9 414121 
245 1 0 |a Advances in Biology and Therapy of Multiple Myeloma  |h [electronic resource] :  |b Volume 2: Translational and Clinical Research /  |c edited by Nikhil C. Munshi, Kenneth C. Anderson. 
260 |a New York, NY :  |b Springer New York :  |b Imprint: Springer,  |c 2013.  |9 724206 
300 |a X, 287 p. 7 illus., 5 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
505 0 |a T cell responses in myeloma -- Novel antigenic targets for immunotherapy in myeloma -- Antibody-based therapies in Multiple Myeloma -- Defining multiple myeloma as a target for DNA gene fusion vaccines -- Harnessing allogeneic immunity for anti-myeloma response -- Dendritic cell and peptide-based vaccination in myeloma -- New Proteasome inhibitors -- Newer Imids -- New agents in myeloma -- Early Combination Studies in MM -- The effect of novel antimyeloma agents on bone metabolism -- Index. 
520 |a Despite the advances in conventional, and novel agent and high dose chemotherapy, multiple myeloma remains incurable. In order to overcome resistance to current therapies and improve patient outcome, novel biologically-based treatment approaches are being developed. Current translational research in multiple myeloma focusing on the development of molecularly-based novel targeted single-agent and combination therapies has great promise to achieve high frequency and durable responses in the majority of patients.   This volume will focus on biology of multiple myeloma, especially on oncogenomic changes, cell signaling pathways and intermediate molecules that are being investigated for development of novel therapies. The book will present newer developments, providing an emphasis on basic science, as well as its significant clinical impact. 
650 0 |a medicine.  |9 566220 
650 0 |a Oncology.  |9 303086 
650 0 |a Toxicology.  |9 302218 
650 1 4 |a Biomedicine.  |9 566246 
650 2 4 |a Cancer Research.  |9 566267 
650 2 4 |a Pharmacology/Toxicology.  |9 302222 
700 1 |a Anderson, Kenneth C.  |e editor.  |9 414122 
710 2 |a SpringerLink (Online service)  |9 143950 
773 0 |t Springer eBooks 
856 4 0 |u http://dx.doi.org/10.1007/978-1-4614-5260-7 
856 |y Перейти в каталог НБ ТГУ  |u https://koha.lib.tsu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=356838 
912 |a ZDB-2-SBL 
950 |a Biomedical and Life Sciences (Springer-11642) 
999 |c 356838  |d 356838